NeOnc Technologies Holdings, Inc. (NTHI) Dividend History

NeOnc Technologies Holdings, Inc. is a healthcare-focused company specializing in the development and commercialization of innovative diagnostic and therapeutic solutions for cancer. The company aims to leverage advanced technologies to improve cancer detection and treatment, providing targeted options to enhance patient outcomes.

Dividend History

NeOnc Technologies Holdings, Inc. currently does not pay dividends

Company News

NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia

NeOnc Technologies received two NIH STTR grants totaling $2.5 million to advance NEO212, a therapeutic compound targeting central nervous system malignancies, with ongoing Phase 1 clinical trials and potential applications in acute myelogenous leukemia and gliomas.

GlobeNewswire Inc.

Page data last updated 08/19/2025 16:44:03 UTC